Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 53 | 1 | 7 | 0 | €922.40 | €1,080.6 | 17.152% |
| Eli Lilly Corp. | 74 | 0 | 11 | 0 | €807.70 | €832.87 | 3.116% |
| arGEN X BV | 1 | 0 | 0 | 0 | €484.20 | €470.00 | -2.933% |
| Vertex Pharmaceuticals Inc. | 57 | 2 | 1 | 0 | €414.75 | €440.14 | 6.121% |
| Medpace Holdings Inc | 18 | 0 | 2 | 0 | €312.60 | €408.19 | 30.578% |
| United Therapeutics | 29 | 1 | 2 | 0 | €324.20 | €341.89 | 5.455% |
| Icon plc | 27 | 0 | 5 | 0 | €267.30 | €327.46 | 22.507% |
| Amgen Inc. | 29 | 1 | 3 | 1 | €291.20 | €304.82 | 4.677% |
| Alnylam Pharmace. | 44 | 0 | 1 | 0 | €244.10 | €275.25 | 12.761% |
| BeiGene Ltd ADR | 8 | 1 | 0 | 0 | €224.00 | €263.72 | 17.733% |
| UCB S.A. | 1 | 0 | 1 | 0 | €166.55 | €210.00 | 26.088% |
| Zoetis Inc. A | 22 | 1 | 1 | 0 | €173.08 | €196.17 | 13.338% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €195.00 | 5.405% |
| Johnson & Johnson | 41 | 1 | 6 | 0 | €146.04 | €192.63 | 31.902% |
| Krystal Biotech | 19 | 0 | 1 | 0 | €161.40 | €184.02 | 14.015% |
| Repligen Corp. | 15 | 0 | 1 | 0 | €131.60 | €183.52 | 39.450% |
| Jazz Pharmaceuticals plc | 33 | 0 | 3 | 0 | €99.66 | €182.69 | 83.312% |
| AbbVie Inc. | 33 | 0 | 0 | 0 | €176.98 | €181.45 | 2.524% |
| Merck KGaA | 8 | 1 | 4 | 0 | €155.30 | €172.00 | 10.753% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €141.00 | €165.00 | 17.021% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €130.00 | €150.00 | 15.385% |
| Novo Nordisk A/S ADR | 25 | 1 | 4 | 0 | €105.00 | €144.48 | 37.600% |
| Merck & Co. Inc. | 32 | 1 | 2 | 0 | €100.00 | €126.38 | 26.380% |
| Abbott Laboratories | 22 | 0 | 3 | 0 | €102.60 | €116.48 | 13.529% |
| Novartis AG ADR | 4 | 0 | 1 | 0 | €104.00 | €112.40 | 8.074% |